Luís Casanova

1.7k total citations · 2 hit papers
20 papers, 1.2k citations indexed

About

Luís Casanova is a scholar working on Pathology and Forensic Medicine, Surgery and Hematology. According to data from OpenAlex, Luís Casanova has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Surgery and 5 papers in Hematology. Recurrent topics in Luís Casanova's work include Genetic factors in colorectal cancer (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Orthopaedic implants and arthroplasty (2 papers). Luís Casanova is often cited by papers focused on Genetic factors in colorectal cancer (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Orthopaedic implants and arthroplasty (2 papers). Luís Casanova collaborates with scholars based in Peru, Spain and United States. Luís Casanova's co-authors include Michele Baccarani, Jiřı́ Mayer, Andreas Hochhaus, George Manos, Giuseppe Saglio, Concepción Boqué, Charles Chuah, Jörge E. Cortes, Hagop M. Kantarjian and Neil P. Shah and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gynecologic Oncology.

In The Last Decade

Luís Casanova

17 papers receiving 1.2k citations

Hit Papers

Final 5-Year Study Results of DASISION: The Dasatinib Ver... 2011 2026 2016 2021 2016 2011 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
    2016 621 citations Jörge E. Cortes, Giuseppe Saglio et al. Journal of Clinical Oncology profile →
  2. Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
    2011 349 citations Alfonso Dueñas‐González, Juan José Zarbá et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luís Casanova Peru 8 638 506 313 307 245 20 1.2k
Kjell Bergfeldt Sweden 16 93 0.1× 39 0.1× 122 0.4× 107 0.3× 331 1.4× 28 1.1k
Debra Sarasohn United States 19 116 0.2× 115 0.2× 273 0.9× 23 0.1× 363 1.5× 36 1.2k
Patricia Ault United States 9 573 0.9× 294 0.6× 18 0.1× 446 1.5× 91 0.4× 25 871
James D. Cox United States 18 170 0.3× 95 0.2× 50 0.2× 37 0.1× 249 1.0× 23 1.1k
Claudia Vener Italy 15 419 0.7× 419 0.8× 35 0.1× 158 0.5× 45 0.2× 43 899
G A Omura United States 11 409 0.6× 108 0.2× 309 1.0× 11 0.0× 201 0.8× 18 1.2k
Konstantinas Povilas Valuckas Lithuania 14 444 0.7× 98 0.2× 58 0.2× 12 0.0× 102 0.4× 36 935
Roger A. Potish United States 22 78 0.1× 43 0.1× 706 2.3× 26 0.1× 378 1.5× 64 1.3k
Canellos Gp United States 20 516 0.8× 412 0.8× 7 0.0× 126 0.4× 79 0.3× 49 1.3k
Cosimo Sacco Italy 18 54 0.1× 155 0.3× 19 0.1× 46 0.1× 213 0.9× 59 1.2k

Countries citing papers authored by Luís Casanova

Since Specialization
Citations

This map shows the geographic impact of Luís Casanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Casanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Casanova more than expected).

Fields of papers citing papers by Luís Casanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luís Casanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Casanova. The network helps show where Luís Casanova may publish in the future.

Co-authorship network of co-authors of Luís Casanova

This figure shows the co-authorship network connecting the top 25 collaborators of Luís Casanova. A scholar is included among the top collaborators of Luís Casanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luís Casanova. Luís Casanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matsunaga, Yuko, Takuhiro Sonoyama, Luís Casanova, et al.. (2020). 1292. Safety Profile of the Novel Siderophore Cephalosporin Cefiderocol in Randomized Phase 2 and Phase 3 Clinical Studies of Serious Gram-Negative Infections. Open Forum Infectious Diseases. 7(Supplement_1). S661–S662. 8 indexed citations
3.
Ruiz, Rossana, et al.. (2017). Cáncer colorrectal en los jóvenes: factores pronósticos y características clínico patológicas en un instituto del cáncer de Perú.. PubMed. 36(1). 35–42. 4 indexed citations
4.
Ruiz, Rossana, et al.. (2017). Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute. Anais Brasileiros de Dermatologia. 92(5). 649–654. 7 indexed citations
5.
Cortes, Jörge E., Giuseppe Saglio, Hagop M. Kantarjian, et al.. (2016). Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial. Journal of Clinical Oncology. 34(20). 2333–2340. 621 indexed citations breakdown →
6.
Bertranou, Fabio, et al.. (2016). Encrucijadas en la seguridad social Argentina.
7.
Enríquez, Daniel, et al.. (2016). Cyclophosphamide, thalidomide and dexamethasone (CTD) as initial therapy for newly diagnosed multiple myeloma patients.. Journal of Clinical Oncology. 34(15_suppl). 8051–8051.
8.
Ruiz, Rossana, et al.. (2016). Colorectal cancer in the young: clinicopathologic features and prognostic factors from a cancer institute in Peru. Americanae (AECID Library). 36(1). 35–42.
9.
Cortes, Jörge E., Giuseppe Saglio, Michele Baccarani, et al.. (2014). Final Study Results of the Phase 3 Dasatinib Versus Imatinib in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Trial (DASISION, CA180-056). Blood. 124(21). 152–152. 59 indexed citations
10.
Montenegro, Paola, et al.. (2014). [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru].. PubMed. 33(1). 34–8. 2 indexed citations
11.
Bertranou, Fabio, et al.. (2013). EL Sistema de Salud del Perú: situación actual y estrategias para orientar la extensión de la cobertura contributiva.. 9 indexed citations
12.
Gómez, Henry, Frank Campana, Silvia P. Neciosup, et al.. (2012). Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma. Hematology/Oncology and Stem Cell Therapy. 5(3). 152–157. 1 indexed citations
13.
Dueñas‐González, Alfonso, Juan José Zarbá, Firuza D. Patel, et al.. (2011). Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix. Journal of Clinical Oncology. 29(13). 1678–1685. 349 indexed citations breakdown →
14.
Montenegro, Paola, Luís Casanova, Cristina Alenda, et al.. (2010). Molecular features of colorectal cancer in Peruvian patients.. Journal of Clinical Oncology. 28(15_suppl). e14043–e14043. 1 indexed citations
15.
Font-Vizcarra, Lluís, et al.. (2010). Less Invasive Fixation of an Interthrocanteric Fracture in an Ankylosed Hip with Cannulated Screws: A Case Report. Hip International. 20(4). 565–567. 6 indexed citations
16.
Muñoz-Mahamud, Ernesto, et al.. (2009). Septic arthritis of the hip caused by nontyphi Salmonella after urinary tract infection. The American Journal of Emergency Medicine. 27(3). 373.e5–373.e8. 6 indexed citations
17.
Barrionuevo, Carlos, et al.. (2007). Extranodal NK/T-cell Lymphoma, Nasal Type: Study of Clinicopathologic and Prognosis Factors in a Series of 78 Cases From Peru. Applied immunohistochemistry & molecular morphology. 15(1). 38–44. 57 indexed citations
18.
Casanova, Luís, et al.. (2007). Pattern of extramedullary relapse in latin patients with acute promyelocytic leukemia (APL) treated with all-trans-retinoic acid (ATRA) and chemotherapy. Journal of Clinical Oncology. 25(18_suppl). 17520–17520. 1 indexed citations
19.
Bori, Guillem, Àlex Soriano, Sebastián García, et al.. (2006). Low sensitivity of histology to predict the presence of microorganisms in suspected aseptic loosening of a joint prosthesis. Modern Pathology. 19(6). 874–877. 40 indexed citations
20.
Vallejos, Carlos, et al.. (1997). Ifosfamide plus Cisplatin as Primary Chemotherapy of Advanced Ovarian Cancer. Gynecologic Oncology. 67(2). 168–171. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kjell Bergfeldt Breakdown of academic impact, for papers by Debra Sarasohn Breakdown of academic impact, for papers by Patricia Ault Breakdown of academic impact, for papers by James D. Cox Breakdown of academic impact, for papers by Claudia Vener Breakdown of academic impact, for papers by G A Omura Breakdown of academic impact, for papers by Konstantinas Povilas Valuckas Breakdown of academic impact, for papers by Roger A. Potish Breakdown of academic impact, for papers by Canellos Gp Breakdown of academic impact, for papers by Cosimo Sacco
Rankless by CCL
2026